Naomi Tanaka
- Molecular Biology top 10%
- Surgery top 5%
- Oncology top 5%
- Epidemiology top 5%
- Hepatology top 1%
- Co-authors
- Yasushi MatsuzakiJunichi ShodaMasato AbeiToshiaki OsugaAkira HondaTadashi IkegamiAkira NakaharaHiroshi Miyazaki
- Topics
- Drug Transport and Resistance Mechanisms (24 papers)Cholesterol and Lipid Metabolism (16 papers)Liver Disease Diagnosis and Treatment (16 papers)
- Cited by
- HepatologyPharmacologyOncology
- Partner nations
- JapanUnited StatesGermany
In The Last Decade
Naomi Tanaka
133 papers receiving 3.2k citations
Peers
Comparison fields: 5 of 123
- Molecular Biology 965
- Surgery 942
- Oncology 750
- Epidemiology 627
- Hepatology 612
Countries citing papers authored by Naomi Tanaka
This map shows the geographic impact of Naomi Tanaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naomi Tanaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naomi Tanaka more than expected).
Fields of papers citing papers by Naomi Tanaka
This network shows the impact of papers produced by Naomi Tanaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naomi Tanaka. The network helps show where Naomi Tanaka may publish in the future.
Co-authorship network of co-authors of Naomi Tanaka
This figure shows the co-authorship network connecting the top 25 collaborators of Naomi Tanaka. A scholar is included among the top collaborators of Naomi Tanaka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naomi Tanaka. Naomi Tanaka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 15 | |
| 2 | 22 | |
| 3 | Daily intake of sulforaphane-rich broccoli sprouts prevents progression of high salt diet-induced gastric atrophy in H.pylori-infected C57/BL6 mice in vivo | 2 |
| 4 | 37 | |
| 5 | 6 | |
| 6 | 11 | |
| 7 | 24 | |
| 8 | 47 | |
| 9 | 63 | |
| 10 | 88 | |
| 11 | 99 | |
| 12 | 8 | |
| 13 | 15 | |
| 14 | 5 | |
| 15 | 2 | |
| 16 | 1 | |
| 17 | 14 | |
| 18 | 10 | |
| 19 | 1 | |
| 20 | 22 |
About Naomi Tanaka
Naomi Tanaka is a scholar working on Hepatology, Pharmacology and Oncology, having authored 135 papers that have together received 3.3k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (24 papers), Cholesterol and Lipid Metabolism (16 papers) and Liver Disease Diagnosis and Treatment (16 papers). The work is most often cited by research in Hepatology (612 citations), Pharmacology (396 citations) and Oncology (750 citations). Naomi Tanaka has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include Yasushi Matsuzaki, Junichi Shoda, Masato Abei, Toshiaki Osuga, Akira Honda, Tadashi Ikegami, Akira Nakahara, Yasushi Matsuzaki, Hiroshi Miyazaki and Toshiya Chiba. Their work appears in journals such as Journal of Biological Chemistry, Gastroenterology and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.